Latest Insider Transactions at Harvard Bioscience Inc (HBIO)
This section provides a real-time view of insider transactions for Harvard Bioscience Inc (HBIO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HARVARD BIOSCIENCE INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HARVARD BIOSCIENCE INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
Michael A. Rossi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,744
-2.48%
|
$14,976
$4.29 P/Share
|
|
Dec 31
2020
|
Kenneth Fletcher Olson Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,299
-3.65%
|
$13,196
$4.29 P/Share
|
|
Nov 01
2020
|
Kenneth Fletcher Olson Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,806
-2.04%
|
$5,418
$3.46 P/Share
|
|
Nov 01
2020
|
Kenneth Fletcher Olson Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,863
-2.06%
|
-
|